Interacting Drugs |
Sulfadiazine vs CYP2C9 Inhibitors (Strong) |
Security Level |
|
Mechanism |
CYP2C9 Inhibitors (Strong): May decrease the metabolism of CYP2C9 Substrates (High risk). |
Management |
Consider therapy modification |
Sulfadiazine vs CYP2C9 Inhibitors (Strong)
Post Review about Sulfadiazine vs CYP2C9 Inhibitors (Strong) Click here to cancel reply.
Other Interactions of Sulfadiazine
Other Interactions of CYP2C9 Inhibitors (Strong)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.